Rinrada Sunandha Pattanayaiying

Dr. Rinrada Sunandha Pattanayaiying

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
RPRinrada Sunandha Pattanayaiying
Rinrada Sunandha Pattanayaiying
ASAmporn Sane
Amporn Sane
PPPenchom Photjanataree
Penchom Photjanataree
CCCatherine N. Cutter
Catherine N. Cutter

Verified
Journal Article
Open access
PDF file
SKSamuel Abiodun Kehinde
Samuel Abiodun Kehinde
WLWai Phyo Lin
Wai Phyo Lin
BLBO Bo LAY
BO Bo LAY
KPKhin Yadanar Phyo
Khin Yadanar Phyo
MSMyat Mon San
Myat Mon San
SCSasitorn Chusri
Sasitorn Chusri
Dementia is marked by progressive cognitive decline linked to oxidative stress, neuroinflammation, and synaptic dysfunction. Curcumin, a natural compound from Curcuma longa, has shown promising neuroprotective effects. This systematic review analyzed 29 preclinical studies using rodent models of dementia induced by chemical, genetic, or dietary methods. The review focused on curcumin’s effects on oxidative stress, inflammation, and cognitive outcomes. All studies assessing malondialdehyde (MDA) reported significant reductions, indicating reduced oxidative stress. Superoxide dismutase (SOD) activity increased in all measured cases, while glutathione (GSH) levels rose in about one-third of studies. A literature search was comprehensively conducted using PubMed, Scopus, AMED, and LILACS databases through April 2024. Curcumin also demonstrated anti-inflammatory properties, with over 80% of studies showing reduced levels of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β. Additionally, 40% of studies noted increases in anti-inflammatory markers like IL-4 and IGF-1. Cognitive performance improved in around 80% of studies, especially in spatial learning and memory. Some studies also reported behavioral improvements, including reduced anxiety and enhanced locomotion. Curcumin demonstrated potent antioxidative, anti-inflammatory, and cognitive-enhancing effects across diverse dementia models. Its ability to modulate multiple pathological pathways highlights its potential as a bioactive compound for mitigating cognitive decline associated with neurodegenerative diseases. However, variability in study design and curcumin formulations suggests the need for standardized protocols and further high-quality research to facilitate clinical translation.

12 June 2025 in Foods
Verified
Journal Article
Open access
PDF file
Zahid QaisraniZahid Qaisrani
Zahid Qaisrani
WLWai Phyo Lin
Wai Phyo Lin
BLBO Bo LAY
BO Bo LAY
KPKhin Yadanar Phyo
Khin Yadanar Phyo
MSMyat Mon San
Myat Mon San
SCSasitorn Chusri
Sasitorn Chusri
Metabolic syndrome (MetS) is a complex condition defined by central obesity, insulin resistance, dyslipidemia, and systemic inflammation. Kefir, a fermented beverage rich in probiotics and beneficial compounds, has emerged as a functional food that may offer metabolic advantages. Nevertheless, preclinical results have been variable. This systematic review and meta-analysis aimed to assess the influence of kefir and its derived compositions on parameters associated with MetS, inflammation, and oxidative stress in rodent studies. A comprehensive literature search was conducted in PubMed, Scopus, AMED, and LILACS through June 2024. Eligible studies involving kefir interventions in rodent MetS models were included. Data extraction followed PRISMA guidelines, with the risk of bias assessed using the CAMARADES and SYRCLE tools. Meta-analyses were performed with a random effects model. Thirty-eight studies involving 1462 rodents (mice and rats) were analyzed. Kefir significantly reduced body weight gain in both mice (MD = –3.33; 95% CI: –4.89 to –1.77) and rats (MD = –41.53; 95% CI: –54.33 to –28.72). In mice, triglycerides and LDL-C levels decreased significantly; in rats, kefir lowered total cholesterol and triglycerides. Insulin levels were reduced (MD = –0.69; 95% CI: –1.16 to –0.22), suggesting improved insulin sensitivity. Several studies also reported reductions in TNF-α, IL-1β, and IL-6. Despite promising results, the high heterogeneity and methodological variability emphasize the need for standardized preclinical protocols and clinical validation. These findings support the role of kefir as a functional food for metabolic health promotion.

24 December 2025 in Foods
Verified
Journal Article
Open access
PDF file
SKSamuel Abiodun Kehinde
Samuel Abiodun Kehinde
ZQZahid Naeem Qaisrani
Zahid Naeem Qaisrani
RPRinrada Sunandha Pattanayaiying
Rinrada Sunandha Pattanayaiying
BLBO Bo LAY
BO Bo LAY
KPKhin Yadanar Phyo
Khin Yadanar Phyo
SCSasitorn Chusri
Sasitorn Chusri
Metabolic syndrome (MetS) and its associated conditions, namely, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), obesity, and polycystic ovary syndrome (PCOS) are characterized by insulin resistance, dyslipidemia, and low-grade inflammation. Curcumin, a polyphenolic compound derived from Curcuma longa Linn., exhibits pleiotropic metabolic and anti-inflammatory properties and has thus been evaluated as a nutraceutical intervention for these conditions, but findings remain inconsistent. This systematic review and meta-analysis evaluated the clinical efficacy of Curcuma longa supplementation on anthropometric, glycemic, lipid, inflammatory, and oxidative stress parameters in adults with MetS or related disorders. A comprehensive search of databases (PubMed, Scopus, AMED, LILACS, and Google Scholar) identified 104 eligible randomized controlled trials (RCTs). The included trials primarily assessed standardized oral turmeric/curcumin supplements and bioavailability-enhanced formulations rather than whole culinary turmeric. Pooled standardized mean differences (SMDs) with 95% confidence intervals (CIs) were computed using random-effects models. Subgroup analyses were conducted by disease category, dose, and formulation. Risk of bias was assessed using the Cochrane RoB 2 tool. Curcumin supplementation significantly reduced fasting blood sugar (SMD = −0.54, 95% CI −0.72 to −0.36) and HbA1c (SMD = −0.41, 95% CI −0.60 to −0.23) in T2DM; decreased triglycerides (SMD = −0.48; 95% CI: −0.70 to −0.25), and LDL cholesterol (SMD = −0.39; 95% CI: −0.59 to −0.18) while elevating HDL cholesterol (SMD = 0.45; 95% CI: 0.25 to 0.65) and total antioxidant capacity (SMD = 0.73; 95% CI: 0.51 to 0.94). Curcuma longa also attenuated systemic inflammation, lowering C-reactive protein (SMD = −0.62; 95% CI: −0.81 to −0.43), TNF-α (SMD = −0.57; 95% CI: −0.80 to −0.34), and IL-6 (SMD = −0.50; 95% CI: −0.70 to −0.29). Heterogeneity was moderate-to-high, reflecting some differences in the formulation, dosage, and duration. Collectively, these findings affirm that Curcuma longa exerts measurable, clinically relevant improvements on glycemic regulation, lipid metabolism, and inflammatory−oxidative balance, supporting its role as a nutraceutical adjunct in metabolic health management, while its bioavailability-enhanced formulations show superior efficacy. Larger, long-term, multicenter RCTs are warranted to confirm durability, optimal dosing, and safety.

5 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
SKSamuel Abiodun Kehinde
Samuel Abiodun Kehinde
ZQZahid Naeem Qaisrani
Zahid Naeem Qaisrani
RPRinrada Sunandha Pattanayaiying
Rinrada Sunandha Pattanayaiying
WLWai Phyo Lin
Wai Phyo Lin
BLBO Bo LAY
BO Bo LAY
SCSasitorn Chusri
Sasitorn Chusri
Background/Objectives: Metabolic syndrome (MetS) is a multifactorial condition characterized by abdominal obesity, dyslipidemia, insulin resistance, hypertension, and chronic inflammation. As its global prevalence rises, there is increasing interest in natural, multi-targeted approaches to manage MetS. Curcuma longa Linn. (turmeric), especially its active compound curcumin, has shown therapeutic promise in preclinical studies. This systematic review and meta-analysis evaluated the effects of Curcuma longa and its derivatives on MetS-related outcomes in rodent models. Methods: A comprehensive search was conducted across six databases (PubMed, Scopus, AMED, LILACS, MDPI, and Google Scholar), yielding 47 eligible in vivo studies. Data were extracted on key metabolic, inflammatory, and oxidative stress markers and analyzed using random-effects models. Results were presented as mean differences (MD) with 95% confidence intervals (CI). Results: Meta-analysis showed that curcumin significantly reduced body weight (rats: MD = −42.10; mice: MD = −2.91), blood glucose (rats: MD = −55.59; mice: MD = −28.69), triglycerides (rats: MD = −70.17; mice: MD = −24.57), total cholesterol (rats: MD = −35.77; mice: MD = −52.61), and LDL cholesterol (rats: MD = −69.34; mice: MD = −42.93). HDL cholesterol increased significantly in rats but not in mice. Inflammatory cytokines were markedly reduced, while oxidative stress improved via decreased malondialdehyde (MDA) and elevated superoxide dismutase (SOD) and catalase (CAT) levels. Heterogeneity was moderate to high, primarily due to variations in curcumin dosage (ranging from 10 to 500 mg/kg) and treatment duration (2 to 16 weeks) across studies. Conclusions: This preclinical evidence supports Curcuma longa as a promising functional food component for preventing and managing MetS. Its multi-faceted effects warrant further clinical studies to validate its translational potential.

31 December 2025 in Preventive Nutrition and Food Science
Verified
Journal Article
Open access
PDF file
CHCHOOSIT HONGKULSUP
CHOOSIT HONGKULSUP
TKTunradee Kumchun
Tunradee Kumchun
TWThanaporn Wilasuwan
Thanaporn Wilasuwan
BJBagher Javadi
Bagher Javadi
CCCatherine Nettles Cutter
Catherine Nettles Cutter
RPRinrada Sunandha Pattanayaiying
Rinrada Sunandha Pattanayaiying
In this study, a novel antimicrobial bilayer film was developed to enhance the shelf-life of raw meat and poultry. The film comprised a fish skin gelatin bottom layer with excellent water absorption capacity and a pullulan top layer incorporating lauric arginate and/or nisin Z, which are both Generally Recognized as Safe antimicrobials. The film's antimicrobial efficacy was evaluated against Pseudomonas aeruginosa and Brochothrix thermosphacta on inoculated chicken breast and sirloin beef. Compared with a commercial absorbent pad, the bilayer film incorporating antimicrobials (bilayer film containing nisin Z and lauric arginate, NiLF) demonstrated the most significant antimicrobial activity (P<0.05). This film reduced P. aeruginosa populations on chicken breast and sirloin beef by 2.51 and 3.40 log10 CFU/cm 2 , respectively, by day 21 of refrigerated storage. Notably, it also eliminated B. thermosphacta from chicken breast and sirloin beef within 14 and 7 days, respectively. The bilayer film containing nisin Z was more effective against B. thermosphacta (3.06 and 5.12 log10 CFU/cm 2 reduction on chicken breast and sirloin beef, respectively), whereas the bilayer film containing lauric arginat better inhibited P. aeruginosa (1.64 and 2.75 log10 CFU/cm 2 reduction on chicken breast and sirloin beef, respectively). By contrast, the commercial absorbent pad showed minimal to no inhibition of either bacterium. Sensory evaluation further demonstrated that the bilayer NiLF consistently achieved the highest scores (P<0.05) across all sensory attributes for chicken and beef. This innovative approach offers a promising alternative to conventional absorbent-pad-based meat preservation methods, potentially improving food safety, reducing food waste, and minimizing environmental impact.